Clinical & Interventional Cardiology



Similar documents
Clinical & Interventional Cardiology

CARDIOLOGIA E ARTE MILAN. December 1 st Grand Hotel Barone di Sassj. Sesto San Giovanni PRELIMINARY PROGRAM

Clinical & Interventional Cardiology

Clinical & Interventional Cardiology

Syncope Unit Project A prospective systematic guideline-based evaluation and treatment of patients referred to the Syncope Units of general hospitals

Rome, Italy December 4-7, 2012 Rome Cavalieri TIMETABLE

International Workshop ANTITHROMBOTIC THERAPY IN ACUTE CORONARY SYNDROMES. Villa Olmo - Como

CATANIA CANDIDATE CITY 12th FINA WORLD SWIMMING CHAMPIONSHIPS (25m) 2014

Atrial fibrillation and heart failure: the ugly and the nasty

EFG Summer Council Meeting May 31 - June 1, 2014

Hot Line Session at European Society of Cardiology (ESC) Congress 2014:

Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations

Jeffrey M. Carlton Heart & Vascular Institute Presents

trial Fibrillation 2009

21st Annual OSF Cardiovascular Symposium

Breakfast symposium: From hospital to home - the focus on the patient

CURRICULUM VITAE Prof. ANTONIO CURNIS

Cardiology Update 2014

Bayer Pharma AG Berlin Germany Tel News Release. Not intended for U.S. and UK Media

Contemporary Management of Cardiovascular Disease

The Copernican Revolution in Ischemic Heart Diseases: the day after

PRIX ITALIA HOTELS FOR ITALIAN AND FOREIGN DELEGATES

Antiplatelet and Antithrombotics From clinical trials to guidelines

Mediterranean School of Oncology

Medical Tourism - The Role of Intervals inCardiovascular Cancer

on End Stage Focus on Idiopathic

PRESIDENTS of the Congress Claudio Allegra (Italy) Pier Luigi Antignani (Italy)

Atahotel Executive Milan, Italy October 21, 2011

Minimally Invasive Cardiac Surgery

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

American College of Allergy, Asthma & Clinical Immunology (ACAAI), USA International Center for Interdisciplinary Studies of Immunology Washington

Atrial Fibrillation: A Different Perspective. Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital

Heart Failure: From Prevention to Intervention

FIBRILLATION ATRIAL 12 INTERNATIONAL. Atrial Fibrillation and Heart Failure: MEETING. Preliminary Program

Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona

Magna Græcia AORtic Interventional Project (MAORI) 3rd SYMPOSIUM COMPLEX DISEASES OF THORACIC AND THORACO-ABDOMINAL AORTA.

58th ANNUAL MEETING OF THE ITALIAN CANCER SOCIETY REVOLUTIONARY ROAD. VERONA SEPTEMBER Palazzo della GRAN GUARDIA. First Announcement

PARKINSON S DISEASE MULTIPLE DOMAINS

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November :38

friday 30 may 2008 brussels belgium Sheraton Brussels Hotel Place Rogier 3 Rogierplein B Brussels

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, Participating Faculty

MUSCULOSKELETAL ONCOLOGY COURSE

Haploidentical Stem Cell Transplantation

CARDIOLOGY 10 YEARS PAST 10 YEARS FUTURE

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY

7th annual ConFerenCe location

Rx Updates New Guidelines, New Medications What You Need to Know

Cardiac Rhythm Device Summit:

New Real-World Evidence Reaffirms Low Major Bleeding Rates for Bayer s Xarelto in Patients with Non-Valvular Atrial Fibrillation

STROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND:

Advanced Cardiac Life Support Provider & Provider Renewal Courses (ACLS & ACLS-R)

Survey of Current Issues in Surgical Anesthesia

STROKE PREVENTION IN ATRIAL FIBRILLATION

INTERNATIONAL RETREAT OF PhD STUDENTS IN IMMUNOLOGY June 2015

CENTRAL MONITORING AUTHORITY for CARDIOLOGY at EU LEVEL

SECOND CARDIOLOGY JOINT SEMINAR. Rome, April 12-13, Cardiovascular Center OLV Clinic Aalst Belgium. and

Dorset Cardiac Centre

What Are Arrhythmias?

PRECHTL S METHOD OF QUALITATIVE ASSESSMENT OF GENERAL MOVEMENTS

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. San Diego, California San Diego Marriott Marquis & Marina October 3 5, Participating Faculty

Update on Indications, Techniques and Controversies for Lead Extraction

How To Get A Dose Of Bayer Healthcare'S Oral Anticoagulant, Xarelto

Failure or significant adverse effects to all of the alternatives: Eliquis and Xarelto

Atrial Fibrillation An update on diagnosis and management

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)

EMA Reaffirms Positive Benefit-Risk Balance of Bayer s Xarelto for Stroke Prevention in Patients with Atrial Fibrillation

Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of Unmet Medical Need in Arterial Thromboembolism

PARTNER PROSPECTUS. ROME November 18th/20th Palazzo Colonna

Presenter: Marco Valgimigli, MD PhD, FESC Erasmus MC, Thoraxcenter Rotterdam The Netherlands

New Frontiers. in Glaucoma. Management. Rome, 7 February 2014 Donna Camilla Savelli Hotel

Practical Information for Participants

SECTION I: Request. SECTION II: Need. Program Description

Scientific Topics. Committees. Invited International Organizing Committee

OPA Continental Cup 2008

SPEAKERS AND CHAIRMEN

INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA. SUMMER SCHOOL OF NEUROSCIENCE (7) Settima scuola estiva di Neuroscienze (7)

Contemporary Management of Cardiovascular Disease

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology

Chronic Vagus Nerve Stimulation: A New Treatment Modality for Congestive Heart Failure

A C C O M M O D A T I O N S D I R E C T I O N S. Exhibitor tables will be accessible at 7:30 a.m.

Brooklyn Stroke Symposium 2015

Kevin Saunders MD CCFP Rivergrove Medical Clinic Wellness SOGH April

Bayer Extends Clinical Investigation of Xarelto for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer

New Oral Anticoagulants. How safe are they outside the trials?

Listen to your heart: Good Cardiovascular Health for Life

Viaggiatori della vita Reiseveranstalter für Italien

Stent for Life Initiative How can we improve system delay and patients delay in STEMI

CARDIAC CARE. Giving you every advantage

SEEC2012 Lecce -Information

SPONSORSHIP/ADVERTIZING OPPORTUNITIES

Introduction. Methods. Study population

Rome, May 2016

MedTASS MEDITERRANEAN TRANSPLANTATION ANESTHESIOLOGY AND SIMULATION SYMPOSIUM. Villa Igiea - PALERMO. April 2013.

SAPIENZA UNIVERSITA DI ROMA UNIVERSITY OF CALIFORNIA SAN DIEGO FIRST ANNUAL CONFERENCE ON TRANSLATIONAL RESEARCH IN MEDICINE

3/25/14. To Clot or Not What s New In Anticoagulation? Clotting Cascade. Anticoagulant drug targets. Anita Ralstin, MS CNS CNP. Heparin.

International Course in Football Management

Cardiology ARCP Decision Aid August 2014

Innovation Platform: Sudden Cardiac Death

Transcription:

Endorsed by Clinical & Interventional Cardiology President: Michele M. Gulizia, MD, FESC ADVANCE PROGRAM 1

PRESIDENT Michele M. Gulizia, MD, FESC ORGANIZED BY Cardiology Division Garibaldi-Nesima Hospital Catania, Italy SCIENTIFIC SECRETARIAT Michele M. Gulizia Director Cardiology Division Garibaldi-Nesima Hospital - Catania, Italy CONGRESS VENUE Sheraton Catania Hotel & Conference Center Via Antonello da Messina, 45 Aci Castello - Catania, Italy OFFICIAL LANGUAGES The Meeting s official languages are English and Italian (simultaneous translation will be provided). Dear Colleagues and Friends, I would like to invite you to attend the 7th edition of the Mediterranean Cardiology Meeting (MCM), April 18-20, in Catania (Italy). Over 1200 participants attended our last meeting with also strong international participation which confirmed the highest interest aroused by this biannual meeting. An outstanding Faculty, selected between the leading experts on these fields, will provide the highest quality teaching with new interactive programs and happenings. Thorough multidisciplinary Courses, Symposia, Debates on Controversial Topics, Clinical Tutorials, Luncheon Panels, Focus on, Meet-the-Expert Sessions, Interactive Cases-Review from Faculty and Attendance, Televoter Sessions, Intercultural Exchanges, Abstract and Poster Sessions the meeting will highlight the current state and the prospective developments for the treatment of: Atrial Fibrillation, Sudden Cardiac Death, Heart Failure, Acute Coronary Syndromes, Global Cardiovascular Prevention, Arterial Hypertension, Pharmacological Therapy, Syncope, Congenital Heart Disease, Cardiac Monitoring Technologies and Genetics. The main target of the meeting is to give the latest update on Clinical & Interventional Cardiology and it is addressed to cardiologists, internists, first aid clinicians, physicians of general medicine, fellows, nurses and technicians with high interest in the whole management of cardiac pathologies. Catania, as one of the most famous historical and cultural locations in the whole Mediterranean area, is the ideal setting for this meeting. It is a particularly lively and fascinating town, rich in marvellous examples of typically Sicilian baroque style, as well as one of the main economic and educational centres in the island, and a key hub of the technological industry. This beautiful city, full of colours, perfumes and flavours, is suspended between the deep blue of the Ionian Sea and the majestic shape of Etna volcano, which dominates the town from afar. Looking forward to seeing you in Catania, sincerely Michele M. Gulizia, MD, FESC President Mediterranean Cardiology Meeting 1

Scientific Committee Angelo Auricchio (Switzerland) Gianluca Botto (Italy) Eugene Braunwald (USA) Michele Brignole (Italy) Joseph Brugada (Spain) Riccardo Cappato (Italy) Paul Casale (USA) Matteo Di Biase (Italy) Giuseppe Di Pasquale (Italy) Bulent Gorenek (Turkey) Michele M. Gulizia (Italy) Karl Heinz Kuck (Germany) Organizing Committee Michele M. Gulizia Mario Audoly Concetto Cacia Nunzia R. Cardillo Giuseppe Di Guardo Giuseppina Maura Francese Cardiology Division Ga r i b a l d i - Ne s i m a Ho s p i ta l - Cata n i a, Ita ly Advisory Board Maurizio Abrignani (Italy) Gianfranco Alunni (Italy) Antonio F. Amico (Italy) Fabrizio Ammirati (Italy) Angelo Auricchio (Switzerland) Alessandro Biffi (Italy) Giuseppe Boriani (Italy) Gianluca Botto (Italy) Michele Brignole (Italy) Joseph Brugada (Spain) Pasquale Caldarola (Italy) Valeria Calvi (Italy) Salvatore Campione (Italy) Roberto Caporale (Italy) Riccardo Cappato (Italy) Paul Casale (USA) Giancarlo Casolo (Italy) Domenico Catanzariti (Italy) Giacomo Chiarandà (Italy) Gennaro Cice (Italy) Furio Colivicchi (Italy) Pietro Delise (Italy) Matteo Di Biase (Italy) Andrea Di Lenarda (Italy) Giuseppe Di Pasquale (Italy) Giuseppe Di Tano (Italy) Francesco Furlanello (Italy) Domenico Gabrielli (Italy) Angelo Gambera (Italy) Gianfranco Gensini (Italy) Giovanna Geraci (Italy) Franco Giada (Italy) Bulent Gorenek (Turkey) Michele M. Gulizia (Italy) Giuseppe Inama (Italy) Helmut Klein (Germany) Karl Heinz Kuck (Germany) Maurizio Eugenio Landolina (Italy) Maurizio Lunati (Italy) Aldo P. Maggioni (Italy) Attilio Maseri (Italy) Jay Metha (USA) Andrea Natale (USA) Ali Oto (Turkey) Eli I. Ovsyshcher (Israel) Fausto J. Pinto (Portugal) Antonio Raviele (Italy) Renato Pietro Ricci (Italy) Francesco Romeo (Italy) Massimo Santini (Italy) Marino Scherillo (Italy) Daniele Mangiameli Anna Portale Salvatore Raciti Natascia Savoca Silvana Anastasi Giuseppe Di Dio Giuditta Gianì Aldo Pietro Maggioni (Italy) Attilio Maseri (Italy) Anna Vittoria Mattioli (Italy) Gianfranco Mazzotta (Italy) Jay Metha (USA) Vincenzo Montemurro (Italy) Loredana Morichelli (Italy) Ernesto Mossuti (Italy) Franco Naccarella (Italy) Federico Nardi (Italy) Andrea Natale (USA) Salvatore Novo (Italy) Ali Oto (Turkey) Eli I. Ovsyshcher (Israel) Giuseppe Palazzo (Italy) Vittorio Panno (Italy) Leonardo Patanè (Italy) Pasquale Perrone Filardi (Italy) Fausto J. Pinto (Portugal) Salvatore Pirelli (Italy) Calogero Puntrello (Italy) Antonio Raviele (Italy) Renato Pietro Ricci (Italy) Carmine Riccio (Italy) Carla Riganti (Italy) Francesco Romeo (Italy) Massimo Santini (Italy) Maurizio Santomauro (Italy) Marino Scherillo (Italy) Gianfranco Sinagra (Italy) Christian Sticherling (Switzerland) Corrado Tamburino (Italy) Pier Luigi Temporelli (Italy) Sakis Themistoclakis (Italy) Salvatore Tolaro (Italy) Giovanni Battista Zito (Italy) Massimo Zoni Berisso (Italy) Guerrino Zuin (Italy) Allied Professionals Course Coordinators Giuseppina Maura Francese (Italy), Angelo Gambera (Italy), Loredana Morichelli (Italy) Endorsed by: 2 3 ENDORSEMENT & AUSPICES EHRA - European Heart Rhythm Association, a Registered Branch of the ESC FIC - Federazione Italiana di Cardiologia WSA - World Society of Arrhythmias Under the auspices of: AIAC - Associazione Italiana di Aritmologia e Cardiostimolazione ANCE - Associazione Italiana Cardiologi Extraospedalieri ANMCO - Associazione Nazionale Medici Cardiologi Ospedalieri ARCA - Associazioni Regionali Cardiologi Ambulatoriali AA Arrhythmia Alliance ECAS - European Cardiac Arrhythmia Society GIEC - Gruppo Intervento Emergenze Cardiologiche GISE - Società Italiana di Cardiologia Invasiva ISE - International Society of Electrocardiology SIC - Società Italiana di Cardiologia SIC SPORT - Società Italiana di Cardiologia dello Sport SOLAECE - Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia

FACULTY M. Abrignani (Trapani, Italy) G. Agnelli (Perugia, Italy) F. Ammirati (Ostia, Italy) S. Berti (Massa, Italy) M. Biffi (Bologna, Italy) L. Bolognese (Arezzo, Italy) G. Boriani (Bologna, Italy) D. Brancaccio (Milan, Italy) L. Calò (Rome, Italy) D. Capodanno (Catania, Italy) R. Caporale (Cosenza, Italy) A. Capucci (Ancona, Italy) G. Casolo (Viareggio, Italy) G. Casu (Nuoro, Italy) G. Ciaramitaro (Palermo, Italy) G. Cice (Naples, Italy) F. Colivicchi (Rome, Italy) C. Cuccia (Brescia, Italy) A. Curcio (Catanzaro, Italy) P. Delise (Conegliano Veneto, Italy) L. De Luca (Rome, Italy) L. De Nicola (Naples, Italy) A. Di Lenarda (Trieste, Italy) G. Di Pasquale (Bologna, Italy) G. Geraci (Palermo, Italy) U. Giordano (Palermo, Italy) C. Greco (Rome, Italy) M. M. Gulizia (Catania, Italy) G. Iervasi (Pisa, Italy) T. Infusino (Catanzaro, Italy) M. Landolina (Milan, Italy) M. Lunati (Milan, Italy) G. Luzzi (Bari, Italy) A.P. Maggioni (Florence, Italy) E. Manzato (Padova, Italy) A. Margonato (Milan, Italy) C. Martignani (Bologna, Italy) G. Mazzotta (La Spezia, Italy) V. Montemurro (Reggio Calabria, Italy) L. Morichelli (Rome, Italy) G. Mureddu (Rome, Italy) S. Novo (Palermo, Italy) E. Occhetta (Novara, Italy) R.A. Osanna (Potenza, Italy) P. Perrone Filardi (Naples, Italy) E. Pisanò (Lecce, Italy) A. Rapacciuolo (Naples, Italy) C. Rapezzi (Bologna, Italy) A. Raviele (Mestre, Italy) R.P. Ricci (Rome, Italy) F. Romeo (Rome, Italy) R. Rossini (Bergamo, Italy) M. Scherillo (Benevento, Italy) L. Testa (Milan, Italy) M. Uguccioni (Rome) S. Urbinati (Bologna, Italy) R. Verlato (Camposampiero, Italy) S. Viani (Pisa, Italy) PROGRAM AT A GLANCE This faculty list may change due to pending confirmation from invited speakers. 4 5

PROGRAM AT A GLANCE SATURDAY APRIL 18 Sat, April 18 PEGASO Room ETNA Room CALIPSO Room Timo Alto Room 7.30-9.00 Registration Registration Allied Professional Registration Registration 9.00-10.30 Minicourse Aortic valve pathology today Interactive Minicourse Risk Stratification in Primary Prevention Allied Professional Program Nursing management of cardiovascular drugs 10.30-11.00 Exhibition Visit & Coffee Break Exhibition Visit & Coffee Break 11.00-12.00 12.00-13.00 Focus on Discovering the second generation of S-ICD Controversies on Dronedarone: Guide Lines and Therapeutic Plan, a glaring dichotomy between Clinical Evidences and Regulatory restrictions Interactive Symposium The management of the patient with Stable CAD: the benefits of the new therapeutic approach Allied Professional Program Organizational aspects and management in arrhythmology - Nursing in hemodynamic Casual Morning Meeting Navigating the evidence: are all NOACs the same? Hyperphosphatemia: a real double-face matter? 13.00-14.30 Luncheon Panel Interactive Luncheon Panel Different therapeutical approach in patients with NSTEMI PCI and in those with pharmacological therapy Casual Meeting The revolution of biological drugs in cardiology: new perspectives for high risk patients 14.30-15.00 Exhibition Visit & Coffee Break 15.00-16.30 ESC-EHRA Joint Symposium Interactive Symposium Rivaroxaban: practical experience examples and sharing clinical cases Allied Professional Program Update in electrophysiology and cardiac pacing - Prevention of infection in cardiology and cardiac surgery Casual Afternoon Meeting Home Monitoring in clinical practice: the role of physician and nurse 16.30-17.00 Plenary Lecture 17.00-18.30 Opening Ceremony 6 7

PROGRAM AT A GLANCE SUNDAY APRIL 19 Sun, April 19 PEGASO Room ETNA Room CALIPSO Room Timo Alto Room 9.00-10.30 ECG Corner The Art of the 12-lead ECG. The basis of daily diagnosis interactive resolution of ECG cases 10.30-11.00 Exhibition Visit & Coffee Break 11.00-12.30 12.30-13.00 13.00-14.30 Symposium Getting the most out of the latest available technologies in order to optimize daily clinical practice Lecture Therapeutic Target of Uricaemia and impact on Health Care Costs Luncheon Panel Patients with high CV risk and hypercholesterolemia: old unresolved problems, new solutions Interactive Symposium Management of dyslipidemia in high cardiovascular risk patients: two clinical cases Interactive Symposium Unmet needs and current practice of stroke prevention in non valvular atrial fibrillation Interactive Luncheon Panel 14.30-15.00 Exhibition Visit Exhibition Visit 15.00-16.30 16.30-17.00 17.00-17.30 17.30-19.00 Symposium The use of large Registries for Quality Improvement for patients with Coronary Artery Disease or Cardiac Arrhythmias Lecture Thyroid hormone treatment in heart failure: when and how? Lecture Inflammation in atherosclerosis- do we need to treat it? Meet the Expert The Heart in Neoplastic patients Interactive Symposium Novel trials and new horizons with dabigatran: protecting patients at high risk of stroke Interactive Meet the Expert 10 Interactive Question / Answers on Pulmonary Hypertension & Pulmonary Embolism Allied Professional Program NAO in nonvalvular atrial fibrillation Exhibition Visit & Coffee Break Allied Professional Program Joint Session: Education as a tool to enhance the health care allied professionals - Nurse and heart failure Allied Professional Program Nursing care in non-invasive ventilation Lecture A defibrillator to bring down mortality: state of the art (S-ICD) Casual Morning Meeting Longevity, Mini-ICD, S-ICD: the right device for every patient. What is the best choice? Casual Morning Meeting Rivaroxaban: operating instructions Casual Afternoon Meeting Dyslipidemic patients: from acute setting to long term management of cardiovascular risk Casual Afternoon Meeting Management of High Risk Cardiovascular Patients 8 9

PROGRAM AT A GLANCE MONDAY APRIL 20 Mon, April 20 PEGASO Room ETNA Room CALIPSO Room Timo Alto Room 9.00-10.30 Minicourse TAVI and MITRACLIP: how to select the Ideal Candidate Interactive Minicourse Pediatric Cardiology: the real needs for daily practice 10.30-11.00 Exhibition Visit & Coffee Break Exhibition Visit & Coffee Break 11.00-12.30 12.30-13.30 Symposium Which oral antiplatelet agents in ACS-PCI patients? Unmet Needs and Possible Solutions Focus on Chest Pain: do we still need a CP Unit or can we integrate it in Cardiology? Interactive Symposium Heart & Sport: 10 Question / Answers on Cardiac Evaluation at Different Age and Different Sports Lecture Changing the face of anticoagulation: 2 years of Dabigatran in Italy BLS-D Course physician BLS-D Course physician Casual Morning Meeting New perspectives in the prevention of thromboembolic risk in Atrial Fibrillation Casual Morning Meeting Innovation in Arrhythmology 13.30-15.00 Luncheon Panel Interactive Luncheon Panel Lunch 15.00-16.30 16.30-17.30 Symposium The Management of Antiplatelet and Anticoagulant Therapy in Surgery Focus on ICD implanted patients: balance between Benefit & Complication Interactive Symposium Atrial Fibrillation & Heart Failure Interactive Focus On Do we need Cardiopulmonary Test in All Heart Failure patients? BLS-D Course physician 10 11

SCIENTIFIC PROGRAM APRIL 18, Legend PEGASO ROOM ETNA ROOM CALIPSO room TIMO ALTO room 12 13

SCIENTIFIC PROGRAM Saturday, April 18 Saturday, April 18 7.30-9.00 Registration Secretariat Desk 9.00-10.30 Interactive Minicourse Etna Room 9.00-10.30 Minicourse Pegaso Room Risk Stratification in Primary Prevention AORTIC VALVE PATHOLOGY TODAY Valvular repair Traditional surgery: which prothesis? TAVI The sutureless 14 15

SCIENTIFIC PROGRAM Saturday, April 18 Saturday, April 18 11.00-12.00 Focus on Pegaso Room 11.00-13.00 Interactive Symposium Etna Room Discovering the second generation of S-ICD Chairmen: U. Giordano (Palermo), E. Occhetta (Novara) Speakers: A. Curcio (Catanzaro), S. Viani (Pisa) The management of the patient with Stable CAD: the benefits of the new therapeutic approach - New ESC guideline 2013: diagnosis and risk stratification - Therapeutic approach in Stable CAD: which news from ANMCO/GICR-IACPR/ GISE Consensus Clinical Cases - Diabetic patient with Stable CAD and with no possible revascularization - Elder patient with previous infarction and Stable CAD with comorbidity - Patient with microvascular angina 16 17

SCIENTIFIC PROGRAM Saturday, April 18 Saturday, April 18 11.30-13.00 Casual Morning Meeting Timo Alto Room 12.00-13.00 Controversies on Pegaso Room Navigating the evidence: are all NOACs the same? Chairmen: F. Romeo (Rome), TBA Stroke prevention in NVAF patients: challenges in clinical practice F. Ammirati (Ostia) Rationale for NOAC dosing strategies: the apixaban case P. Perrone Filardi (Naples) Dronedarone: Guide Lines and Therapeutic Plan, a glaring dichotomy between Clinical Evidences and Regulatory restrictions Chairmen: M.M. Gulizia (Catania), A. Raviele (Mestre) Pro: A. Capucci (Ancona) Cons: G. Boriani (Bologna) HYPERPHOSPHATEMIA: A REAL DOUBLE-FACE MATTER? Chairmen: D. Brancaccio (Milan), TBA - No, It s a pure Kidney disease! L. De Nicola (Naples) - Yes, It s a Kidney-Cardio disease! G. Cice (Naples) 18 19

SCIENTIFIC PROGRAM Saturday, April 18 Saturday, April 18 13.00-14.30 Luncheon Panel Pegaso Room 13.00-14.30 Casual Meeting Timo Alto Room 13.00-14.30 Interactive Luncheon Panel Etna Room Different therapeutical approach in patients with NSTEMI PCI and in those with pharmacological therapy Chairmen: G. Mazzotta (La Spezia), TBA Discerning criteria for choosing reperfusion strategy R.A. Osanna (Potenza) Updates about medical management (of ACS) TBA The revolution of biological drugs in cardiology: new perspectives for high risk patients Chairmen: M.M. Gulizia (Catania), F. Romeo (Rome) Cardiovascular prevention in Italy: where we are today and where we need to be G. Mureddu (Rome) Statin intolerance and adherence management V. Montemurro (Reggio Calabria) Role of PCSK9i in the difficult cardiovascular prevention C. Rapezzi (Bologna) Therapeutic options and prognosis of NSTEMI patient not eligible for invasive strate G. Casolo (Viareggio, LU) 20 21

SCIENTIFIC PROGRAM Saturday, April 18 Saturday, April 18 14.30-16.30 Interactive Symposium Etna Room 15.00-16.30 ESC-EHRA Joint Symposium Pegaso Room Rivaroxaban: real life experience e clinical cases sharing Chairmen: G. Di Pasquale (Bologna), M. Uguccioni (Rome) Evidences from Dresda registry L. Calò (Rome) Interactive discussion of clinical cases in stroke prevention in atrial fibrillation and treatment of pulmonary embolism 15.00-16.30 Casual Meeting Timo Alto Room Home Monitoring in clinical practice: the role of physician and nurse Chairmen: F. Ammirati (Ostia), TBA Speakers: R.P. Ricci (Rome) L. Morichelli (Rome) Atrial Fibrillation clinical cases: First case G. Casu (Nuoro) Second case G. Boriani (Bologna) Pulmonary embolism C. Cuccia (Brescia) 22 23

Saturday, April 18 16.30-17.00 Plenary Lecture Pegaso Room 17.00-18.30 Opening Ceremony Pegaso Room SCIENTIFIC PROGRAM APRIL 19, Legend PEGASO ROOM ETNA ROOM CALIPSO room TIMO ALTO room 24 25

SCIENTIFIC PROGRAM Sunday, April 19 Sunday, April 19 9.00-10.30 ECG Corner Pegaso Room 9.00-11.00 Interactive Symposium Etna Room The Art of the 12-lead ECG. The basis of daily diagnosis Interactive resolution of ECG cases Management of dyslipidemia in high cardiovascular risk patients: two clinical cases Chairmen: A. Di Lenarda (Trieste), TBA First Clinical Case F. Colivicchi (Rome) Second Clinical Case M. Abrignani (Trapani) Third Clinical Case E. Manzato (Padova) 26 27

SCIENTIFIC PROGRAM Sunday, April 19 Sunday, April 19 10.00-11.30 Casual Meeting Timo Alto Room 11.00-12.30 Symposium Pegaso Room Longevity, Mini-ICD, S-ICD: the right device for every patient. What is the best choice? Chairman: G. Ciaramitaro (Palermo) Getting the most out of the latest available technologies in order to optimize daily clinical practice Chairmen: P. Delise (Conegliano Veneto, TV), M. Landolina (Milan) Speakers: E. Pisanò (Lecce), G. Luzzi (Bari) Adapting ventricular pacing in order to increase responsiveness to CRT M. Biffi (Bologna) SureScan technology: the ultimate solution for CIED patients undergoing MRI A. Rapacciuolo (Naples) Reveal LINQ: a revolution in subcutaneous cardiac monitoring T. Infusino (Catanzaro) More than 100.000 AF patients treated with One Shot technology: what we know and what we expect R. Verlato (Camposampiero, PD) 28 29

SCIENTIFIC PROGRAM Sunday, April 19 Sunday, April 19 11.00-13.00 Interactive Symposium Etna Room 11.30-13.00 Casual Meeting Timo Alto Room Unmet needs and current practice of stroke prevention in non valvular atrial fibrillation Chairmen: S. Novo (Palermo), TBA Translating clinical data in real word use M. Scherillo (Benevento) Rivaroxaban: operating instructions Chairmen: M.M. Gulizia (Catania), A.P. Maggioni (Florence) Speakers: G. Agnelli (Perugia), TBA Interactive case based session R. Caporale (Cosenza), G. Geraci (Palermo) 30 31

SCIENTIFIC PROGRAM Sunday, April 19 Sunday, April 19 12.30-13.00 Lecture Pegaso Room 13.00-14.30 Luncheon Panel Pegaso Room Therapeutic target of uricaemia and impact on health care costs Patients with high CV risk and hypercholesterolemia: old unresolved problems, new solutions Hypercholesterolemia: what is the real dimension of the problem? Therapeutic inappropriateness and inertia in management of dyslipidemias in patient with high CV risk Treatment of high CV risk patient with hypercholesterolemia: we are close to real innovation 13.00-14.30 Interactive Luncheon Panel Etna Room 32 33

SCIENTIFIC PROGRAM Sunday, April 19 Sunday, April 19 15.00-16.30 Symposium Pegaso Room 15.00-17.00 Interactive Symposium Etna Room The use of large Registries for Quality Improvement for patients with Coronary Artery Disease or Cardiac Arrhythmias Novel trials and new horizons with dabigatran: protecting patients at high risk of stroke Chairmen: M.M. Gulizia (Catania), TBA First Clinical Case C. Martignani (Bologna) Second Clinical Case A. Margonato (Milan) Third Clinical Case L. Testa (Milan) 34 35

SCIENTIFIC PROGRAM Sunday, April 19 Sunday, April 19 15.00-16.30 Casual Meeting Timo Alto Room 16.30-17.00 Lecture Pegaso Room Dyslipidemic patients: from acute setting to long term management of cardiovascular risk Chairmen: C. Greco (Rome) Sustainability of statin treatments F. Colivicchi (Rome) Thyroid hormone treatment in heart failure: when and how? Chairman: TBA Speaker: G. Iervasi (Pisa) Statin-beyond LDL control S. Urbinati (Bologna) 36 37

SCIENTIFIC PROGRAM Sunday, April 19 Sunday, April 19 16.30-18.00 Casual Afternoon Meeting Timo Alto Room 17.00-17.30 Lecture Pegaso Room Management of High Risk Cardiovascular Patients Inflammation in atherosclerosis: do we need to treat it? Dyslipidemia treatment after ACS New evidences on the protective role of n-3 PUFAs in patients with ACS Dyslipidemie management in the renal patient 38 39

Sunday, April 19 17.00-19.00 Interactive Meet the expert Etna Room 10 Interactive Question / Answers on PulmOnary Hypertension & PulmOnary Embolism 17.30-19.00 Meet the expert Pegaso Room The Heart in Neoplastic patients SCIENTIFIC PROGRAM APRIL 20, Cardiotoxicity of Anthracycline-like Chemotherapy agents: Cardioprotection and Management Trastuzumab, novel ErbB2 Inhibitors and Antiangiogenic Agents: Cardioprotection and Management of toxicity of Target Therapy Management of Atrial Fibrillation and VTE in Cancer Patients: there is a role for NOAC? QT Monitoring in Chemotherapy and Management of Cardiac Devices during Radiation Therapy Legend PEGASO ROOM ETNA ROOM CALIPSO room TIMO ALTO room 40 41

SCIENTIFIC PROGRAM Monday, April 20 Monday, April 20 9.00-10.30 Minicourse Pegaso Room 10.00-11.30 Casual Morning Meeting Timo Alto Room TAVI and MITRACLIP: how to select the Ideal Candidate 9.00-10.30 Interactive Minicourse Etna Room Pediatric Cardiology: the real needs for daily practice New perspectives in the prevention of thromboembolic risk in Atrial Fibrillation Chairmen: M.M. Gulizia (Catania), TBA Unmet medical needs in the prevention of thromboembolic events in AF M. Lunati (Milan) NOACs in the treatment of AF: Clinical Trials and RWE M. Scherillo (Benevento) The role of NOACs in pts undergoing electrical cardioversion TBA 42 43

SCIENTIFIC PROGRAM Monday, April 20 Monday, April 20 11.00-12.30 Symposium Pegaso Room 11.00-12.30 Interactive Symposium Etna Room WHICH ORAL ANTIPLATELET AGENTS IN ACS-PCI PATIENTS? Unmet Needs and Possible Solutions Heart & Sport: 10 Question / Answers on Cardiac Evaluation at Different Age and Different Sports Chairmen: S. Berti (Massa), TBA The essential need and the right solution for ensuring the best outcome in STEMI patients D. Capodanno (Catania) Current Controversies in the administration of antiplatelet therapy in NSTEMI- PCI: Pretreatment vs Non-Pretreatment, what to do? L. Bolognese (Arezzo) 12.30-13.30 Focus on Pegaso Room Chest Pain: do we still need a CP Unit or can we integrate it in Cardiology? Do SCA-Diabetic patients deserve a more targeted treatment? R. Rossini (Bergamo) Switching: the right strategy to improve patients treatment L. De Luca (Rome) 44 45

SCIENTIFIC PROGRAM Monday, April 20 Monday, April 20 12.30-13.30 Lecture Etna Room 12.30-14.00 Casual Meeting Timo Alto Room Changing the face of anticoagulation: 2 years of Dabigatran in Italy INNOVATION IN ARRHYTHMOLOGY Multi Point Pacing: improving the outcome of the CRT patients Contact Force Sensor: changing the routine of AF ablation procedures Leadless Pacemaker: changing paradigms in bradyarrhythmia treatment 46 47

SCIENTIFIC PROGRAM Monday, April 20 Monday, April 20 13.30-15.00 Luncheon Panel Pegaso Room 13.30-15.00 Interactive Luncheon Panel Etna Room 48 49

SCIENTIFIC PROGRAM Monday, April 20 Monday, April 20 15.00-16.30 Symposium Pegaso Room 16.30-17.30 Focus on Pegaso Room THE MANAGEMENT OF ANTIPLATELET AND ANTICOAGULANT THERAPY IN SURGERY ICD implanted patients: balance between Benefit & Complication Before Coronary Artery By-pass Surgery After Coronary Artery By-pass Surgery In Extracardiac Surgery 16.30-17.30 Interactive Focus on Etna Room Do we need CardiopulmOnary Test in All Heart Failure patients? Double Antiplatelet Therapy in association with Oral Anticoagulation 15.00-16.30 Interactive Sympsosium Etna Room Atrial Fibrillation & Heart Failure 50 51

TRAINING COURSE ON Cardiology and Intensive Care FOR ALLIED PROFESSIONALS APRIL 18-19, (Italian Allied Professionals only) Program Chairs: Giuseppina Maura Francese Angelo Gambera Loredana Morichelli President: Michele M. Gulizia, MD, FESC 52 53

TRAINING COURSE FOR ALLIED PROFESSIONALS Cardiology and Intensive Care 19-20 Aprile Saturday, April 18 Saturday, April 18 Calipso Room Calipso Room 9.00 Registration of participants 9.15 Greetings from the President and the Program Chairs NURSING MANAGEMENT OF CARDIOVASCULAR DRUGS 9.30 To ensure therapeutic procedures: Nurse responsibilities 9.45 Risk management in therapy administration 10.00 Nursing management in Cardiology 10.15 The predictable risk in drug management 10.30 Discussion ORGANIZATIONAL ASPECTS AND MANAGEMENT IN ARRHYTHMOLOGY 11.00 Nursing Research 11.15 Risk management in arrhythmology 11.30 Nurse in quality control NURSING IN HEMODYNAMIC 12.30 The cath lab: equipment and organizational model 12.45 Nursing care during hemodynamic procedures 13.00 Nursing care before and after procedures 13.15 Discussion UPDATE IN ELECTROPHYSIOLOGY AND CARDIAC PACING 14.30 Management of cardiac implantable devices during ablation procedures or surgery 14.45 MRI conditional implantable devices: what to do before, during and after scanning 15.00 Inappropriate and unnecessary shocks. How to prevent them? 15.15 News and perspectives in electrophysiology 15.30 Discussion 11.45 The informed consent 54 55

TRAINING COURSE FOR ALLIED PROFESSIONALS Cardiology and Intensive Care 19-20 Aprile Saturday, April 18 Sunday, April 19 Calipso Room Calipso Room PREVENTION OF INFECTION IN CARDIOLOGY AND CARDIAC SURGERY 16.00 Definition of infection related to care practices 15.15 Risk factors 16.30 Monitoring systems and survey 16.45 Prevention Strategies 17.00 Discussion NAO IN NONVALVULAR ATRIAL FIBRILLATION 9.00 Non-valvular atrial fibrillation: how to define it? 9.15 Thromboembolic and hemorrhagic risk stratification 9.30 The new oral anticoagulants: a valuable opportunity for therapy tailoring 9.45 Monitoring of anticoagulant activity and management of bleeding 10.00 Discussion JOINT SESSION: EDUCATION AS A TOOL TO ENHANCE THE HEALTH CARE ALLIED PROFESSIONALS 10.30 The Educational Dossier 10.45 The Residential Education 11.00 On-the-job Training 11.15 The FAD Education 11.30 Discussion 56 57

TRAINING COURSE FOR ALLIED PROFESSIONALS Cardiology and Intensive Care 19-20 Aprile Sunday, April 19 Sunday, April 19 Calipso Room Calipso Room NURSE AND HEART FAILURE NURSING CARE IN NON-INVASIVE VENTILATION 12.00 What is the nurse role in diagnostic and therapeutic pathways during the patient hospital stay 12.15 Continuity of care after discharge: nurse role during the follow-up 12.30 The terminal patient: symptom and pain control. Is it possible to switch off the automatic implantable defibrillator? 12.45 Health education and counseling. What communication tools for patients and their relatives 13,00 Discussion 15.00 Acute respiratory failure 15.15 Non-invasive ventilation: theoretical aspects and indications 15.30 CPAP AND BPAP 15.45 Nursing care to the patient in non-invasive ventilation 16.00 Discussion 16.30 LECTURE A defibrillator to bring down mortality: state of the art (S-ICD) 58 59

Basic Life Support Course and Defibrillation APRIL 20, 60 61

BLS-D COURSE FOR ALLIED PROFESSIONALS 20 Aprile Monday, April 20 Monday, April 20 8.30-9.00 Course registration 9.00-9.30 INTRODUCTION - SLIDES: Survival Chain Adults early defibrillation - BLS-D algorithm Pediatric early defibrillation - (differences) 9.30-10.00 CPR ADULTS: Check the state of consciousness CPR Protective equipment Chest compressions Gasping and safety lateral positioning Breathing without chest compressions CPR and two rescuers Airway obstruction Heimlich manouvres Calipso Room 13.30-14.00 CPR ON INFANTS: Pediatric CPR Survival Chain Rescue breathing Subdislocation of the jaw Chest compression Airway obstruction Differences in infant and child 14.00-16.30 Training on mannequins adults, infant and child 16.30-18.30 Final evaluation: theoretical and practical skills 10.15-12.30 Training on mannequins adults 12.30-13.30 Lunch break Calipso Room 10.00-10.15 Break 62 63

INFORMATION General Scientific Registration Payment Congress Venue Hotel Practical 64 65

GENERAL INFORMATION CONGRESS VENUE SHERATON CATANIA HOTEL & CONFERENCE CENTER Via Antonello da Messina, 45-95021 Aci Castello - Catania (CT) Tel. +39 095 7114111 - Fax. +39 095 271380 www.sheratoncatania.com SCIENTIFIC SECRETARIAT MICHELE M. GULIZIA Cardiology Division - Garibaldi-Nesima Hospital Via Palermo, 636-95122 Catania, Italy Tel. +39 095 7598502 - Fax + 39 095 7598505 e-mail: michele.gulizia@alice.it ORGANIZING SECRETARIAT ADRIA CONGREX Via Sassonia, 30-47922 Rimini, Italy Tel. +39 0541 305830-305811 - Fax + 39 0541 305842 e-mail: info@mcmweb.it - Web site: www.mcmweb.it VISA REQUIREMENTS An official invitation letter for visa may be requested to the Organizing Secretariat. This invitation will not imply any obligation from the Organization to provide any kind of financial contribution. SECRETARIAT AND REGISTRATION DESK OPENING HOURS For Groups April 17, 2.30 pm - 6.30 pm For appointment please contact the Organizing Secretariat For Individuals April 18, 8.00 am - 7.00 pm April 19, 8.00 am - 7.00 pm April 20, 8.00 am - 5.00 pm OFFICIAL LANGUAGES The Meeting official languages are English and Italian with simultaneous translation. EXHIBITION The technical and pharmaceutical exhibition area will be located at the Congress Venue, close to the conference rooms. The exhibition opening hours will follow the timetable of the scientific sessions. Companies that are interested in presenting their products or taking up other sponsorship options can contact the Organizing Secretariat, Adria Congrex. 66 67